©The Author(s) 2025.
World J Virol. Sep 25, 2025; 14(3): 108754
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.108754
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.108754
Figure 1 Global epidemiology of hepatitis C virus infection and its cardiovascular implications.
Worldwide, hepatitis C virus (HCV) prevalence is estimated at 2.5%-5%, with an annual incidence of approximately 23.7 cases per 100000 population. Chronic HCV infection increases cardiovascular risk by 20%-30%, with an incidence of cardiomyopathy of 1.5 per 1000 person-years. HCV: Hepatitis C virus; MI: Myocardial infarction; HF: Heart failure.
- Citation: Bharaj IS, Singh G, Brar AS, Kacheria A, Kahlon J, Mohmand B, Sohal A, Yeneneh BT. Hepatitis C virus-associated cardiomyopathy: A review of pathogenesis. World J Virol 2025; 14(3): 108754
- URL: https://www.wjgnet.com/2220-3249/full/v14/i3/108754.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i3.108754